10-Oxo docetaxel
CAS: 167074-97-7
Ref. 3D-FO26648
1mg | 517,00 € | ||
2mg | 924,00 € | ||
5mg | 1.449,00 € | ||
10mg | 2.551,00 € | ||
25mg | 5.228,00 € |
Produktinformation
- (aR,bS)-b-[[(1,1-Dimethylethoxy)carbonyl]amino]-a-hydroxybenzenepropanoic Acid (2aR,4S,4aS,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12- (benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5,6-dioxo-7,11-methano
10-Oxo docetaxel is a taxane that is used in the treatment of cancer. It has shown to be effective in the treatment of breast, lung, prostate, and bladder cancers. The impurities of this drug are 10-deacetylbaccatin III (10-DAB) and 10-deacetyltaxol (10-DT). These impurities can be quantified using LC/MS/MS methods with a limit of detection at 0.05% for 10-DAB and 0.1% for 10-DT. The limits of quantification are determined by the peak area response and signal to noise ratio. Bortezomib is an impurity that cannot be removed by chromatographic methods but can be removed by supercritical CO2 extraction. This impurity may cause significant adverse effects on patients receiving this drug as bortezomib inhibits the proteasome which is needed to break down proteins within cells that are damaged or no
Chemische Eigenschaften
Technische Anfrage zu: 3D-FO26648 10-Oxo docetaxel
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.